DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Sonazoid is an investigational drug.
There have been 11 clinical trials for Sonazoid. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2015.
The most common disease conditions in clinical trials are Focal Nodular Hyperplasia, Breast Neoplasms, and Liver Diseases. The leading clinical trial sponsors are GE Healthcare, Thomas Jefferson University, and National Cancer Institute (NCI).
There are eight hundred and forty-five US patents protecting this investigational drug and seven international patents.
Recent Clinical Trials for Sonazoid
|Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCC||Second Affiliated Hospital, School of Medicine, Zhejiang University||Phase 3|
|Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal Cancer||National Cancer Institute (NCI)||Early Phase 1|
|Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal Cancer||Sidney Kimmel Cancer Center at Thomas Jefferson University||Early Phase 1|
Top disease conditions for Sonazoid
Top clinical trial sponsors for Sonazoid
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Sonazoid||Start Trial||Perfluoroalkanes and perfluoroalkane and sulphur hexafluoride compositions as aerosol propellants||Start Trial|
|Sonazoid||Start Trial||Polycarbonate of alkyl cyclohexylidene bisphenol||Bayer Aktiengesellschaft (Leverkusen, DE)||Start Trial|
|Sonazoid||Start Trial||Tight binding of proteins to surfaces||Washington Research Foundation (Seattle, WA)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Sonazoid||European Patent Office||EP0374656||2008-12-23||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|